Responses
Oral Presentations
Clinical osteoporosis: new insights
OP0105 The Predictors for 12 Months Efficacy of Denosumab, An anti-RANKL Antibody, on Osteoporosis in Patients with Rheumatoid Arthritis from Multicenter Study (TBCR-Bone)
Compose a Response to This Article
Other responses
No responses have been published for this article.